Researchers have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special ...

University of Missouri researchers and collaborators have developed a new chemical tool that could help lower the cost of ...

University of Missouri researchers and collaborators have developed a new chemical tool that could help lower the cost of ...

Royalty Pharma saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 68 to 72. Please watch the video at Investors.com - How To Scale Out Of Losing Stocks ...

Understand the significant growth trajectory of the Purified Boron Trifluoride segment, which is expected to reach US$232.9 ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

Coral Gables, FL-based Catalyst Pharmaceuticals , Inc. (NASDAQ:CPRX), a $2.69 billion market cap biopharmaceutical company that has delivered an impressive 54% return to shareholders over the past ...

Emcure Pharmaceuticals Limited, one of India's leading pharma companies announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

This was the stock's second consecutive day of losses.

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most ...